Receipt of radiotherapy was highest among patients with ER/PR negative and ER/PR positive cancers treated with hormone therapy, those who received surgery in an urban area (Edmonton or Calgary), those who received adjuvant chemotherapy and in those younger than 80 years of age, regardless of the cancer stage. This evidence concerns the gene ESR1 and cancer.